GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Other Current Receivables

Gubra AS (OCSE:GUBRA) Other Current Receivables : kr26.0 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Other Current Receivables?

Gubra AS's Other Current Receivables for the quarter that ended in Dec. 2023 was kr26.0 Mil.

Gubra AS's quarterly Other Current Receivables declined from Dec. 2022 (kr8.39 Mil) to Jun. 2023 (kr7.22 Mil) but then increased from Jun. 2023 (kr7.22 Mil) to Dec. 2023 (kr26.01 Mil).

Gubra AS's annual Other Current Receivables increased from Dec. 2021 (kr5.61 Mil) to Dec. 2022 (kr8.39 Mil) and increased from Dec. 2022 (kr8.39 Mil) to Dec. 2023 (kr26.01 Mil).


Gubra AS Other Current Receivables Historical Data

The historical data trend for Gubra AS's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Other Current Receivables Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
2.91 5.56 5.61 8.39 26.01

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial 5.61 - 8.39 7.22 26.01

Gubra AS Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Gubra AS Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Gubra AS's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (OCSE:GUBRA) Business Description

Industry
Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines